Tuesday, December 13, 2016

Best Clean Energy Stocks To Buy Right Now

Allergan (NYSE:AGN) is one of the many biotech stocks that has been beaten down in the last one and a half year. In this article I will indicate 4 reasons why I think the company and the stock can perform well in the future.

Reason #1: Diversified sources of revenue and rich pipeline

One of the characteristics that I like in Allergan is its rich portfolio of drugs. As we can see in the table below, Allergan has 17 products that generated more than $150 million in the first nine months of 2016, and 14 of them are still growing, in most cases at double digit rates. While someone would argue that Allergan's large share of revenue related to Botox (19.1%) is a risk factor, I see this particular segment as a source of strength for the company.

Best Clean Energy Stocks To Buy Right Now: Pilgrim's Pride Corporation(PPC)

Advisors' Opinion:
  • [By John Udovich]

    Thanksgiving is almost here but the exit of both Pilgrim's Pride Corporation (NYSE: PPC) and Smithfield Foods (NYSE: SFD) to focus on their chicken or pork businesses (the latter was also acquired by the Chinese) leaves just two big Thanksgiving turkey stocks, Hormel Foods Corporation (NYSE: HRL) and Seaboard Corporation (NYSEAMEX: SEB), for investors to consider. According to the American Far Bureau, a 16-pound turkey will (on average) come in at a total of $22.74 this year or roughly $1.42 per pound for a decrease of 2 cents per pound or a total of 30 cents per whole turkey, compared to 2015. The price drop may be a transition back to the norm as the significant bird flu outbreak last year hurt the nation��s supply of both turkey and eggs.

  • [By Ben Levisohn]

    BMO Capital Markets analysts Kenneth Zaslow and Patrick Chen took a look at the valuations of Tyson Foods (TSN) and Pilgrim’s Pride (PPC) and decided they were afraid of heights. They explain why they cut Tyson Foods to Market Perform from Outperform…

Best Clean Energy Stocks To Buy Right Now: Durect Corporation(DRRX)

Advisors' Opinion:
  • [By Roberto Pedone]

    One under-$10 name that's starting to move within range of triggering a major breakout trade is Durect (DRRX), which develops pharmaceutical products based on its proprietary drug delivery technology platforms. This stock is off to a hot start in 2013, with shares up sharply by 41%.

    If you take a look at the chart for Durect, you'll notice that this stock has been trending sideways for the last two months and change, with shares moving between $1 on the downside and $1.34 on the upside. Shares of DRRX have now started to flirt with that $1.34 major resistance level on Thursday, since the stock has hit an intraday high of $1.35 a share with strong upside volume flows. This could be signaling that shares of DRRX are ready to break out above the upper-end of its recent range and trend substantially higher.

    Traders should now look for long-biased trades in DRRX if it manages to break out above some near-term overhead resistance levels at $1.34 to $1.35 a share with high volume. Look for a sustained move or close above those levels with volume that hits near or above its three-month average action of 679,480 shares. If that breakout triggers soon, then DRRX will set up to re-fill some of its previous gap down zone from May that started near $1.80 a share. If DRRX gets into that gap with volume, then this stock could easily trend north of $2 a share.

    Traders can look to buy DRRX off any weakness to anticipate that breakout and simply use a stop that sits right below some key near-term support levels at its 50-day moving average of $1.16 a share or its 200-day moving average at $1.11 a share. One can also buy DRRX off strength once it clears those breakout levels with volume and then simply use a stop that sits a comfortable percentage from your entry point.

Best Clean Energy Stocks To Buy Right Now: Constellium N.V.(CSTM)

Advisors' Opinion:
  • [By Jim Robertson]

    On Monday, our Under the Radar Movers�newsletter suggested that small cap aluminum products and solutions stock�Constellium NV (NYSE: CSTM) is looking like a short-term long bullish trade:

  • [By Monica Gerson]

    Constellium NV (NYSE: CSTM) is estimated to report its quarterly earnings at $0.06 per share on revenue of $1.18 billion.

    Qiwi PLC (NASDAQ: QIWI) is expected to report its quarterly earnings at $13.85 per share on revenue of $2.70 billion.

Best Clean Energy Stocks To Buy Right Now: Ultra Petroleum Corp.(UPL)

Advisors' Opinion:
  • [By STOCKPICKR]

    As energy commodity prices have sold off in recent months, so too have the E&P stocks that pull those resources out of the ground. And Ultra Petroleum (UPL) has been no exception. The good news is that you don't need to be an expert technical trader to figure out why this stock looks toxic here -- the setup in shares of Ultra Petroleum is about as simple as they get.

    UPL is bouncing its way lower in a textbook downtrending channel, a price setup that's formed by a pair of parallel trendlines that have kept UPL range-bound since April. The price channel in UPL identifies the high-probability range for shares to stay within, and so, with shares pressing up against resistance for the eighth time since this price channel kicked off, it makes sense to be a seller on the next bounce lower.

  • [By Ben Levisohn]

    Our peer group is up an average of 46% over the past 4 weeks in response to a 30% rebound in the 12-month strip NYMEX oil price. Some of the largest gainers include Hold and Sell rated stocks that we would not chase such as�Denbury Resources (Sell, +138%), Halcon Resources (HK) (Sell, +147%), Jones Energy (JONE) (Hold, +166%), Rex Energy (REXX) (Sell, +60%), Sanchez Energy (SN) (Hold, +93%), Ultra Petroleum (UPL) (Sell, +61%), and�Whiting Petroleum (Hold, +103%), which have outperformed the E&P Index (+32%) over the same time period. Balance sheets and/or well level returns remain challenged for these companies despite improved oil prices. While we believe oil markets should re-balance over the next 12 to 15 months, the recent recovery to $40 could reverse during 2Q16 as bloated inventories continue to rise, new volumes from Iran pressure an oversupplied market, and a highly anticipated decline in non-OPEC supply (especially in the U.S.), is not as steep as expected. The risk of an oil price retracement, which would significantly pressure the recent out-performers, outweighs the upside in these stocks, in our view. However, we are raising our target prices on Buy rated�Anadarko Petroleum ($54 from $48), Concho Resources (CXO) ($120 from $109), Matador Resources (MTDR) ($22 from $21),�Noble Energy (NBL) ($40 from $34), SM Energy (SM) ($22 from $15), Rice Energy ($14 from $12), Pioneer Natural Resources (PXD) ($155 from $135),�Continental Resources ($32 from $28), and Parsley Energy (PE) ($24 from $23). We believe our Buy-rated stocks are better positioned to weather challenging oil markets.

No comments:

Post a Comment